Procurement Summary
Country: Spain
Summary: Supply of Ganciclovir, Epoprostenol, Levetiracetam, Meropenem, Asoc Emtricitabine/Tenofovir Disop, Tobramycin, Abacavir, Sunitinib, Irinotecan, Lapatinib, Dalbavancin, Nintedanib and Trientine Dihydrochloride
Deadline: 04 Sep 2026
Posting Date: 05 Aug 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 146579473
Document Ref. No.: 540962-2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: EUR 9186213.92
CPV Classification
33600000 - Pharmaceutical products
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
1 - L1_ GANCICLOVIR (DOE) 2 - L2_ EPOPROSTENOL (DOE) with sucrose, arginine and sodium hydroxide as excipients 3 - L3_ LEVETIRACETAM (DOE) 4 - L4_ LEVETIRACETAM (DOE) UNIDOSIS 5 - L5_MEROPENEM (DOE) 6 - L6_ EMTRICITABINE/TENOFOVIR DISOPROXIL ASSOCIATION (DOE) 7 - L7_TOBRAMYCIN (DOE) INHALED 8 - L8_ABACAVIR (DOE) 9 - L9_SUNITINIB (DOE) 10 - L10_IRINOTECAN (DOE) 11 - L11_LAPATINIB (DOE) 12 - L12_ DALBAVANCINA (DOE) 13 - L13_NINTEDANIB (DOE) indicated in idiopathic pulmonary fibrosis and other diseases interstitial pulmonary (ILD) UNIDOSIS 14 - L14_NINTEDANIB (DOE) indicated in combination with indicated in non-small cell lung cancer UNIDOSIS 15 - L15_TRIENTINE (DOE) DIHYDROCHLORIDE Supply of Ganciclovir, Epoprostenol, Levetiracetam, Meropenem, Asoc Emtricitabine/Tenofovir disop, Tobramycin, Abacavir, Sunitinib, Irinotecan, Lapatinib, Dalbavancin, Nintedanib and Trientine dihydrochloride L1_ GANCICLOVIR (DOE) L2_ EPOPROSTENOL (DOE) with sucrose, arginine and sodium hydroxide as excipients L3_ LEVETIRACETAM (DOE) L4_ LEVETIRACETAM (DOE) UNIDOSIS L5_MEROPENEM (DOE) L6_ EMTRICITABINE/TENOFOVIR DISOPROXILE ASSOCIATION (DOE) L7_INHALED TOBRAMYCIN (DOE) L8_ABACAVIR (DOE) L9_SUNITINIB (DOE) L10_IRINOTECAN (DOE) L11_LAPATINIB (DOE) L12_ DALBAVANCINA (DOE) L13_NINTEDANIB (DOE) indicated in idiopathic pulmonary fibrosis and other interstitial lung diseases (ILD) UNIDOSIS L14_NINTEDANIB (DOE) indicated in combination with indicated in non-small cell lung cancer UNIDOSIS ...
Document Type: Contract Notice Reference Number: 2026/00466 Contract Type: supplies Estimated Value: 9186213.92 - EUR Authority Type: ra Doc Title: Suministro de Ganciclovir, Epoprostenol, Levetiracetam, Meropenem, Asoc Emtricitabina/Tenofovir disop, Tobramicina, Abacavir, Sunitinib, Irinotecan, Lapatinib, Dalbavancina, Nintedanib y Trientina dihidrocloruro Dispatch Date: 2026-08-04 Publish Date: 2026-08-05 Submission Date: 2026-09-04
Documents
Tender Notice